Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance. - Wikidata - wikimedia - TriplyDB

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.

http://www.wikidata.org/entity/Q39615584

about

Autoantibodies in chronic hepatitis C: A clinical perspective Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.Occult hepatitis C: how convincing are the current data?Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.Host genetic determinants in hepatitis C virus infection.Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.ANA testing in the presence of acute and chronic infections.Algorithmic Approach With Clinical Pathology Consultation Improves Access to Specialty Care for Patients With Systemic Lupus Erythematosus.Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.Autoantibody profile in individuals with chronic hepatitis C.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.

P2860

Q28088556-E55C8EA4-1CB8-4DF2-9047-ED0B5B144F5D Q28483978-6FFC8F0A-8DFC-4938-9855-AF22F90B57D4 Q33378075-AEBC3D98-C9FF-47ED-AEAA-DDF22F9C0C1B Q33395436-BF664CE2-C29B-4BEC-B7AA-E2BE669BEF71 Q34626547-0F170644-9C93-45B6-A23A-ABC8944EFF43 Q35753723-3FBCF056-A8ED-41D2-9FBD-C1D9BA2DFABF Q37672213-82463C16-119F-4527-A2DF-ACD819D9A7D1 Q38799673-CBEF4C10-383B-410B-B164-D8FA9FABDF66 Q38924166-993CB790-3993-4875-83BD-0ECC5C3B3A29 Q39130785-D27DAA5C-9DE8-4905-A97D-8C1102728CCA Q40526929-FAB2134F-ACAC-4438-9CD6-0E888F7DDFCD Q50933723-82965D69-A99C-4FC6-8EF2-D3628684876E Q55027429-5BB0908A-AD41-4553-93B3-A4DCDB08DD1E

P2860

Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.

http://www.wikidata.org/entity/Q39615584

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Antinuclear antibodies (ANA) i ...... tivity and clinical relevance.

@en

type

label

Antinuclear antibodies (ANA) i ...... tivity and clinical relevance.

@en

prefLabel

Antinuclear antibodies (ANA) i ...... tivity and clinical relevance.

@en

P1433

Q39615584-3C3CB059-AEBB-43CA-ACCD-F016DACB7B75

P1476

Q39615584-030213B3-4A85-4673-954D-6B3820209AF5

P2093

Q39615584-1FBBBDF6-780B-4910-8D6D-A5C7772160D5

Q39615584-333FBE3C-4161-4541-8A0F-D094D4D107FC

Q39615584-4FF64793-D6AC-472D-AD59-2FE27F98586D

Q39615584-840E6483-2A20-4011-97CB-CE3E76D525F7

Q39615584-86365E34-267C-4F40-8757-D1A97FA52537

Q39615584-9BD19467-F5BA-47BE-916B-7E6F9474569B

Q39615584-A2FEAB4B-21E2-4DBE-A923-D2633A051DFD

Q39615584-BCA2C98D-9631-4279-908F-37331F3F416B

Q39615584-C8CF7827-2778-441F-8802-54C8A360BAB7

Q39615584-CECA009B-85C1-44C3-93CB-F18B3078845E

P2860

Q39615584-09197B1E-E446-4D06-86DE-3C028E58316D

Q39615584-133438C4-1827-4C8B-835C-0098F1119B05

Q39615584-18177CAC-1C3D-41F3-9AF5-7EE6A50551A9

Q39615584-64BAE76B-CB14-46FE-9BBC-7B4A20459519

Q39615584-783E7E39-C6F5-4A22-ACBE-B344EB306C04

Q39615584-C53825CE-9DCC-4F7B-9B65-0CD13635233B

P304

Q39615584-334582C6-DB31-4EC3-B394-649C297BA736

P31

Q39615584-D35BC879-70FA-4D11-A1AD-B222306DF41E

P356

Q39615584-8A1F0A8B-4FE6-4F3F-BA9F-4D2C68F18AFF

P433

Q39615584-698887A1-F805-4486-88A1-0842DCE0AE7A

P478

Q39615584-EF4AA00A-D84B-4EA9-8124-5F8FA6F045AC

P577

Q39615584-C9D4C3A9-51A6-4889-BDD3-25C4D3A4AD30

P698

Q39615584-3AB95018-871C-4860-977B-4D7D8D5EDF20

P356

J.1365-2893.2004.00530.X

P1433

Journal of Viral Hepatitis

P1476

Antinuclear antibodies (ANA) i ...... tivity and clinical relevance.

@en

P2093

Alberti A

http://www.w3.org/2001/XMLSchema#string

Braconier JH

http://www.w3.org/2001/XMLSchema#string

Chiaramonte M

http://www.w3.org/2001/XMLSchema#string

Goldin RD

http://www.w3.org/2001/XMLSchema#string

Hall AJ

http://www.w3.org/2001/XMLSchema#string

Kelleher P

http://www.w3.org/2001/XMLSchema#string

Marshall S

http://www.w3.org/2001/XMLSchema#string

Thomas HC

http://www.w3.org/2001/XMLSchema#string

Thursz MR

http://www.w3.org/2001/XMLSchema#string

Yee LJ

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and staging of chronic hepatitis

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

Auto-antibodies in hepatitis C.

High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.

Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population.

Sex differences in autoimmune disease

P304

459-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2893.2004.00530.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15357653

http://www.w3.org/2001/XMLSchema#string